Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF) (2020 - 2024)
Whitehawk Therapeutics (WHWK) posted quarterly Depreciation & Amortization (CF) of $1000.0 for Q1 2026, down 98.25% year-over-year from $57000.0 in Q1 2025, and down 95.45% quarter-over-quarter from $22000.0 in Q4 2025.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF) (2020 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Depreciation & Amortization (CF) for 11 consecutive years, with $1000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 98.25% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $43900.0 (down 82.67% YoY), while the FY2025 annual figure was $79000.0, down 59.07% from the prior year.
- Depreciation & Amortization (CF) slipped to $1000.0 in Q1 2026 per WHWK's latest filing, from $22000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $100000.0 in Q4 2024 and bottomed at $1000.0 in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $39717.6 across 5 years, with a median of $44000.0 in 2023.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 3600.0% — and 2026, when it plunged 98.25%.
- Whitehawk Therapeutics' Depreciation & Amortization (CF) stood at $46000.0 in 2022, then fell by 4.35% to $44000.0 in 2023, then surged by 127.27% to $100000.0 in 2024, then tumbled by 78.0% to $22000.0 in 2025, then plunged by 95.45% to $1000.0 in 2026.
- Business Quant data shows WHWK's Depreciation & Amortization (CF) at $1000.0 in Q1 2026, $22000.0 in Q4 2025, and $5600.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 27,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |